HST Global

HSTC · OTC

$0.70+$0.5663 (+423.56%)TodayMarket closed ·
No price history for this range.

About HSTC

HST Global, Inc. is a health and wellness biotechnology company, which engages in the acquisition of a network of wellness centers that are focused on the homeopathic and alternative treatments of late-stage cancer. The company is headquartered in Virginia Beach, Virginia. The firm is focused on developing and /or acquiring a network of wellness centers worldwide that is primarily focused on the homeopathic and alternative treatment of late-stage cancer. The firm intends to acquire innovative products for the treatment of life-threatening diseases. The firm primarily focuses on homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late-stage cancer and/or life-threatening diseases. The company is also focused on funding and developing cutting-edge software solutions. The firm has not generated any revenue.

Employees
0
Headquarters
Virginia Beach, Virginia
Listed
Sep 24, 1986
Sector
Health Care
Industry
Biotechnology

HSTC key statistics

Market cap
209.33M
Price-earnings ratio
0.00
Dividend yield
—
Average volume
434
Volume
100
Open price
$0.70
High today
$0.70
Low today
$0.70
52 Week high
$1.05
52 Week low
$0.0101

HST Global (HSTC) at a glance

As of Oct 19, 2026, HST Global (HSTC) shares are priced at $0.70, giving the company a market cap of 209.33M and a price-to-earnings ratio of 0.00.

Volume so far is 100 shares, below the average of 434 shares a day.

Over the past year HST Global has ranged from $0.0101 to $1.05, and now sits 66% of the way up that range.

Similar companies

Companies in the same industry as HST Global

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.